Pediatric Pulmonary Vascular Disease or Adult Pulmonary Vascular Disease

Activation of Platelets and the Complement System in Mice with Schistosoma-Induced Pulmonary Hypertension

Claudia Mickael, Mariah Jordan, Janelle N. Posey, Rubin N. Tuder, Eva Nozik, Joshua M. Thurman, Kurt R. Stenmark, Brian B. Graham, Cassidy DelaneyUniversity of Colorado Anschutz Medical Campus. University of California, San Francisco.United States American Journal of Physiology Lung Cellular and Molecular PhysiologyAm J Physiol Lung Cell Mol Physiol 2024; DOI: 10.1152/ajplung.00165.2024 AbstractSchistosomiasis-induced pulmonary hypertension (PH) […]

Activation of Platelets and the Complement System in Mice with Schistosoma-Induced Pulmonary Hypertension Read More »

Covid-19-induced pulmonary hypertension in children, and the use of phosphodiesterase-5 inhibitors

Herlina Dimiati Dimas Arya Umara, Iflan NaufalUniversitas Syiah Kuala,Indonesia F1000 ResearchF1000Res 2022; DOI: 10.12688/f1000research.53966.2 AbstractRespiratory tract infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first occurred in Wuhan, China, in December 2019 and was declared as a pandemic by WHO. The interaction between the 2019 coronavirus disease (COVID-19) and pulmonary hypertension (PH) in children

Covid-19-induced pulmonary hypertension in children, and the use of phosphodiesterase-5 inhibitors Read More »

Swyer-James-MacLeod Syndrome in a Patient with Eisenmenger Syndrome

Dolunay Gürses, Merve Oğuz, Doğangün Yüksel, Furkan Ufuk, Münevver YılmazPamukkale University Medical School. Turkey Archives of the Turkish Society of CardiologyTurk Kardiyol Dern Ars 2024; 52: 460-463DOI: 10.5543/tkda.2023.59829 AbstractSwyer-James-MacLeod syndrome is characterized radiologically by hyperlucency in a single lung lobe, accompanied by reduced vascularity, alveolar hyperdistention, and air trapping, without bronchial airway obstruction. The most common

Swyer-James-MacLeod Syndrome in a Patient with Eisenmenger Syndrome Read More »

Genetics and precision genomics approaches to pulmonary hypertension

Eric D. Austin, Micheala A. Aldred, Mona Alotaibi, Stefan Gräf, William C. Nichols, Richard C. Trembath, Wendy K. ChungVanderbilt University Medical Center. Indiana University School of Medicine. University of California San Diego. University of Cambridge. Cincinnati Children’s Hospital Medical Center and University of Cincinnati College of Medicine. King’s College London. Boston Children’s Hospital. United States

Genetics and precision genomics approaches to pulmonary hypertension Read More »

Inhaled Nanoparticulate Systems: Composition, Manufacture and Aerosol Delivery

Heidi M. Manour, Priya Muralidharan, Don Hayes Jr.University of Arizona. Ohio State University College of Medicine. United States Journal of Aerosol Medicine and Pulmonary Drug DeliveryJ Aerosol Med Pulm Drug Deliv 2024; 37: 202-218 DOI: 10.1089/jamp.2024.29117.mk AbstractAn increasing growth in nanotechnology is evident from the growing number of products approved in the past decade. Nanotechnology can

Inhaled Nanoparticulate Systems: Composition, Manufacture and Aerosol Delivery Read More »

Multiple biomarkers are equivalent to clinical pulmonary arterial hypertension survival risk models

Megan Griffiths, Catherine E. Simpson, Jun Yang, Dhananjay Vaidya, Melanie K. Nies, Stephanie Brandal, Rachel Damico, Paul Hassoun, D. Dunbar Ivy, Eric D. Austin, Michael W. Pauciulo, Katie A. Lutz, Lisa J. Martin, Erika B. Rosenzweig, Raymond L. Benza, William C. Nichols, Cedric Manlhiot, Allen D. EverettJohns Hopkins University. University of Texas Southwestern. Children’s Hospital

Multiple biomarkers are equivalent to clinical pulmonary arterial hypertension survival risk models Read More »

Comorbidities and complications in adult and paediatric patients with pyruvate kinase deficiency: Analysis from the Peak Registry

Andreas Glenthøj, Rachael F. Grace, Carl Lander, Eduard J. van Beers, Bertil Glader, Kevin H. M. Kuo, Yan Yan, Bryan McGee, Audra N. Boscoe, Junlong Li, Paola BianchiCopenhagen University Hospital – Rigshospitalet. Dana-Farber/Boston Children’s Cancer and Blood Disorders Center and Harvard Medical School. Thrive with PK Deficiency. University Medical Center Utrecht and Utrecht University. Stanford

Comorbidities and complications in adult and paediatric patients with pyruvate kinase deficiency: Analysis from the Peak Registry Read More »

Cancer-Associated Thrombotic Microangiopathy: Literature Review and Report of Five Cases

L. Posado-Domínguez, A. J. Chamorro, E. Del Barco-Morillo, M. Martín-Galache, D. Bueno-Sacristán, E. Fonseca-Sánchez, A. Olivares-HernándezUniversity Hospital of Salamanca and University of Salamanca. Spain LifeLife 2024; 14:DOI: 10.3390/life14070865 AbstractThrombotic microangiopathy (TMA) is an anatomopathological lesion mediated by endothelial dysfunction and characterized by the creation of microthrombi in small vessels. In patients with cancer, it may be

Cancer-Associated Thrombotic Microangiopathy: Literature Review and Report of Five Cases Read More »

Non-invasive prediction of pulmonary vascular disease-related exercise intolerance and survival in non-group 1 pulmonary hypertension

Yogesh N. V. Reddy, Hilary Dubrock, Paul M. Hassoun, Anna Hemnes, Evelyn Horn, Jane A. Leopold, Franz Rischard, Erika B. Rosenzweig, Nicholas S. Hill, Serpil C. Erzurum, Gerald J. Beck, Stephen C. Mathai, Monica Mukherjee, W. H. Wilson Tang, Barry A. Borlaug, Robert P. Frantz and the PVDOMICS Study GroupMayo Clinic. Johns Hopkins University. Vanderbilt

Non-invasive prediction of pulmonary vascular disease-related exercise intolerance and survival in non-group 1 pulmonary hypertension Read More »

Case report: Paracorporeal lung assist device for 215 days as a bridge-to-lung transplantation in a patient with bronchopulmonary dysplasia and severe pulmonary hypertension

Sebastian G. Michel, Maja Hanuna, Joseph Pattathu, Jelena Pabst von Ohain, Christian Schneider, Theresa Kauke, Nikolaus Kneidinger, Juergen Behr, Katrin Milger, Juergen Barton, Tobias Veit, Christine Kamla, Christoph Mueller, Robert Dzieciol, Lauren Christen, Michael Irlbeck, Roland Tomasi, Jan Abicht, Patrick Scheiermann, Matthias Feuerecker, Robert Dalla-Pozza, Marcus Fischer, Andre Jakob, Matthias Hermann, Nikolaus Haas, Christian Hagl,

Case report: Paracorporeal lung assist device for 215 days as a bridge-to-lung transplantation in a patient with bronchopulmonary dysplasia and severe pulmonary hypertension Read More »

Scroll to Top